2 recruiting, 1 completed. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Rituximab infusion: new trials by email Literature Review of Rituximab infusion trials Research Report on Rituximab infusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders Rituximab infusion, Placebo infusion, Premedications - Anti-MAG Neuropathy | Phase 3 | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 90 | 2023-06-29 | 2025-11-24 |
| Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases Rituximab Infusion - Multiple Sclerosis | Phase 4 | Completed | Wake Forest University Health Sciences | 19 | 2013-02-01 | 2018-09-07 |
| Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy Rituximab Infusion, Oral Cyclosporine - Nephrotic Syndrome, Proteinuria | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 30 | 2010-12-22 | 2026-10-26 |
Autoimmune Diseases (1) · Glomerulonephritis, Membranous (1) · Kidney Diseases (1) · Multiple Sclerosis (1) · Nephrotic Syndrome (1) · Proteinuria (1)
Centre Hospitalier Universitaire de Saint Etienne (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Wake Forest University Health Sciences (1)
United States (2) · France (1)
LeAnne D Kennedy, PharmD (1) · Meryl A Waldman, M.D. (1)